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ABSTRACT 
Protein  metabolism  of Yoshida  ascites  hepatoma  cells was  studied  in  the  early 
phase  of logarithmic  proliferation  and  in  the  following  stage  in  which  cell mass 
remains  constant  (resting phase).  The rate of protein  synthesis was measured by 
a  short-time incorporation  of [SH]lysine,  while degradation  was concurrently  as- 
sessed by following the decrease of specific activity of [~'C]lysine-labeled proteins. 
Most of the labeled amino acid injected intraperitoneally into the animal was im- 
mediately available for the tumor cells,  with only a  minor loss towards the extra- 
ascitic compartment. It was thus possible to calculate the dilution of the isotope in 
the ascitic pool of the lysine, which increased concurrently with the ascitic plasma 
volume.  Amino  acid  transport  capacity did  not  change in  the log  vs. the  resting 
cells. This fact permitted the correction of the specific activity of the proteins syn- 
thesized by tumors in the two phases, taking into account the dilution effect. Pro- 
tein  synthesis was found to proceed at a  constant rate throughout each of the two 
phases,  although  it  was  30%  lower  during  the  resting  as  compared  to  the  log 
phase.  When cell mass attained the steady-state, protein degradation occurred at 
such a  level as to balance the synthesis. Throughout the resting phase the amount 
of lysine taken up by the cells and  renewed from the blood remained unchanged. 
Protein  turnover,  as  studied  in  subceUular  fractions,  exhibited  a  similar  rate  in 
nuclei and microsomes, where it proceeded at a higher level than in mitochondria. 
On  the whole, the results encourage the use of the Yoshida ascites hepatoma as a 
suitable model for studying protein turnover in relation to cell growth in vivo. 
INTRO DUCT ION 
Some in vitro studies  indicate that protein synthe- 
sis  proceeds  at  similar  rates throughout  discrete 
proliferation  and  resting  stages  in  normal  and 
neoplastic  cells  (28,  14). On  the  other  hand, 
significant protein turnover I seems to be confined 
to the resting phase (13,  17-19, 28). 
The  purpose  of  this  work  was  an  in  vivo 
1  The term turnover is used in this paper tO indicate the 
overall process of renewal of cell proteins, including both 
their synthesis and degradation (see reference 2). 
approach  to  the  study  of  protein  metabolism 
relative to  the  different  stages  of growth  of Yo- 
shida  ascites  hepatoma  cells.  This  tumor  was 
considered a suitable model to work with,  for the 
following  reasons:  (a)  the  tumor  exhibits  two 
well-defined  stages  of  growth,  the  first  being 
characterized  by  a  logarithmic  proliferation,  the 
second by a long period of resting (4); (b) growth 
may accurately be checked by cell counting;  (¢) it 
is possible to follow the modifications of the milieu 
in which the cells are living. 
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Male  Wistar  rats weighing 220-250  g  were used. They 
were  given  water  and  a  commercial  complete  diet 
(Zoofarm,  Padua,  Italy)  ad  libitum,  up  to  the  times 
indicated. 
Yoshida ascites hepatoma  130 was maintained in the 
above-mentioned  strain  of rats.  Experimental  animals 
were  inoculated  intraperitoneally  (i.p.)  with  3.107  cells 
taken  from  the  peritoneal  cavity  of  a  tumor-bearing 
animal,  7  days  after  transplantation.  At  established 
times,  tumor-bearing  animals  were  anesthetized  with 
diethyl-ether and  exsanguinated by heart puncture;  the 
ascitic  fluid  (ascitic plasma  plus tumor cells) was then 
withdrawn by a  syringe, and then the peritoneal cavity 
was opened and thoroughly washed with known volumes 
of ice-cold 0.25  M  sucrose. 
Estimation  of Tumor and Ascitic 
Plasma  Volumes 
Tumor  volume  (ascitic  plasma  +  tumor  cells)  was 
determined by subtracting the volume of sucrose wash- 
ings from the total  fluid  recovered. The volume of the 
ascitic  plasma  was  obtained  by  subtracting  the  cell 
volume calculated on the basis of the intracellular water 
(see below) from the tumor volume. 
Ascitic and  blood  plasmas were separated  from  the 
cells by centrifugation at  1,000 g  for 10 min. 
Washing, Homogenization,  and 
Fractionation  of Hepatoma  Cells 
All manipulations were performed in a  cold room at 
2°C  using  chilled  materials.  Tumor  cells were  washed 
twice with cold 0.25 M sucrose. Preliminary experiments 
have shown that a  1% loss of cell proteins is due to the 
washings  under  these  conditions.  Washed  cells  were 
resuspended in 4  vol of 0.25  M  sucrose. Aliquots of the 
cell suspensions were used for protein determination (see 
below). Tumor cell suspensions were homogenized with a 
Dounce-type  stainless-steel  homogenizer  fitted  with  a 
Teflon ball. By centrifugation, the following cell fractions 
were obtained: (a) nuclear  fraction, from the homogenate 
at 500 g for 10 min; (b) mitochondrialfraction,  from the 
nuclear supernate at  10,000 g for 15 min; (c) microsomal 
fraction,  from the mitochondrial supernate at  100,000  g 
for 60 min. All fractions were washed twice with ice-cold 
sucrose, 
Intracellular  Water 
Total  water  of  sedimented  cells  was  estimated  by 
subtracting the dry weight from the wet weight. Water 
trapped  intercellularly  was  calculated  from  the  ratio 
between  [3H]inulin  radioactivity extracted  in trichloro- 
acetic acid (TCA) from the pellet and the radioactivity 
per  milliliter  of  the  supernate  of  an  aliquot  of  cell 
suspension,  lntracellular  water  was  calculated  by  sub- 
tracting  the trapped  water  from  the total  water  of the 
sediment. 
Amino A cid  Transport 
Tumors  were  used  on  the  4th  and  10th  days  after 
transplantation, when they reached, respectively, a 30-35 
and  80-90  ml volume. For the in vitro experiments the 
cells of three tumors of the same size were harvested and 
pooled  after centrifugation  of the  ascitic  fluid,  washed 
three  times  with  Krebs-Henseleit  bicarbonate  buffer 
equilibrated  with  02  +  CO2  (95:5),  and  finally  resus- 
pended in an appropriate volume of the same buffer with 
or without the addition of glucose (final concentration 8 
raM). The incubation mixture contained 5.106  cells/ml. 
Initial rates of amino acid uptake were determined by 
incubating the cells in the presence of 1 ~tCi of e-[~4C]ly - 
sine in Krebs-Henseleit bicarbonate buffer at 37°C for 5 
rain. The final concentration of lysine in the mixture was 
0.5  mM.  The  intracellular  accumulation  of the  tracer 
amino acid was determined according to Guidotti et al. 
(l 1,  12). 
In the in vivo experiments, 50 t~Ci of e-[SH]lysine were 
injected into the animals.  I  min later, an aliquot of the 
ascitic fluid  was withdrawn and  the cells were immedi- 
ately separated from the ascitic plasma by centrifugation 
at 500 g  for 5 rain at 37°C. The intracellular accumula- 
tion  of the tracer  amino  acid  was calculated  from  the 
ratio  between  the  radioactivity  per  milliliter  of  the 
intracellular water and the TCA-soluble radioactivity per 
milliliter of the ascitic plasma (distribution ratio). 
Labeling and Counting of the Cell Proteins 
The  labeling  procedure  used  for  studying  protein 
synthesis and  degradation  was  derived  from  the  tech- 
nique proposed by Arias et al. (2) for the determination 
of the turnover of different protein species in the same 
animal. 
In the  standard experiment, one isotopic form of an 
amino  acid  ([~4C]lysine)  was  administered  i.p.  to  rats 
bearing Yoshida ascites hepatoma, and the decline of the 
~C  radioactivity  of  tumor  proteins  was  followed.  At 
various  intervals  after  the  first  isotope  injection,  the 
animals received i.p. a second administration of the same 
amino acid in a  different isotopic form ([~H]lysine) and 
were killed 80 min later. The decrease of ~4C radioactiv- 
ity  of  tumor  proteins  was  used  to  estimate  protein 
degradation,  while the incorporation of [3H]lysine  into 
tumor  proteins  was  taken  as  an  index  of the  rate  of 
protein synthesis. 
Labeling experiments were carried out with groups of 
rats bearing tumors that, unless otherwise indicated, had 
been transplanted 5 days earlier. At the beginning of the 
experiments, the rats were given i.p. 2 ml of physiological 
saline containing 6 #mol (10 #Ci) of L-[~'C]lysine. Then, 
at the times indicated, the animals were given a  further 
injection  of 2  ml  of physiological  saline  containing  6 
umol (50 tsCi) of L-[aH]lysine.  Initial values  of protein 
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the beginning of the experiments, received i.p.  2  ml of 
physiological saline containing both 10 pCi of [14C]lysine 
and 50 pCi of [3H]lysine in a total amount of 6 pmol of 
the amino acid. 
In  all  cases,  the  rats  were  killed  80  rain  after  the 
administration of the [3H]lysine.  It is at this time that the 
highest incorporation of isotope into the tumor proteins 
could be detected. The animals were fasted  12 h  before 
each  isotope  injection and for the 80 rain immediately 
before killing. Radioactivity was determined on weighed 
aliquots  of  proteins  precipitated  by  5%  (wt/vol;  final 
concentration) TCA and purified according to Siekevitz 
(22). Samples were solubilized with 0.5 ml of NCS tissue 
solubilizer (Amersbam/Searle Corp., Arlington Heights, 
I11.) and counted in a toluene-based scintillation mixture 
(5  g  of 2,5-diphenyloxazolone and  300  mg  of 2,2'-p- 
phenylen-bis 5-phenyloxazolone in 1 liter of toluene). A 
Mark  1  liquid  scintillation  spectrometer  (Nuclear- 
Chicago Corp.,  Des  Plaines, Ill.) was employed, with a 
setting  for  the  double  label  isotope  counting,  the  aH 
window counting 10% of "C counts and the "C window 
containing no aH counts. Counting efficiencies were 38% 
for ~4C and 15% for 3H. Samples had uniform quenching 
as judged from internal standards. 
Assays 
Proteins were determined according to the method of 
Lowry  et  al.  (16).  L-lysine  concentration in blood and 
ascitic plasma was estimated after deproteinization with 
5% sulfosalicylic acid (3) by the method of Spackman et 
al. (23),  using a  Unichrome amino acid analyzer (Beck- 
man  Instruments, Inc., Spinco Div.,  Palo Alto, Calif.). 
Specific radioactivity of free lysine (either "C or 3H) was 
determined according to Cappugi et al. (6). 
Radiochemieals 
The radiochemicals used  were  L-[U-l~C]lysine mon- 
ohydrochloride (spec act  10 mCi/mmol),  L-[4,5-~H]Iy - 
sine (n) monobydrochlorkle (spec act 250 mCi/mmol), 
and [3H]inulin (spec act 300 mCi/mmol) obtained from 
The Radiochemical Centre, Amersham, England. 
RESULTS  AND  DISCUSSION 
Because  of a  certain variability of the time-course 
of  tumor  growth,  total  mass  was  considered  a 
better reference than the age of the tumors. 
Fig.  1  shows  that  the  ascitic  plasma  volume 
increases  at  an  uniform  rate throughout the time 
studied,  whereas  the  cell  mass,  after  a  phase  of 
logarithmic  proliferation  (log  phase),  ceases  to 
increase when the tumor volume reaches 40  50 ml 
(6-7  days  after  transplantation)  and thereafter  it 
remains unchanged (resting phase). 
This  time-course  is  consistent  with  the  growth 
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FIGURE  l  Relationships between cell mass expressed as 
milligrams  of  cell  protein  (&  &),  ascitic  plasma 
volume  (O----©),  and  ascitic  plasma  proteins 
(O  O)  in  Yoshida  ascites  hepatomas  of  different 
total volumes.  Rats  were  killed  at  various times after 
transplantation. 
curve observed in the Yoshida ascites hepatoma by 
Bombara and  Morabito (4). 
The  trypan  blue  exclusion  test  and  glycogen 
synthesis,  as  studied  histochemically (7),  indicate 
that during the resting phase and up to the death of 
the animal all tumor cells are alive. 
The analysis of protein pattern performed by gel 
filtration on G-200 Sephadex and by electrophore- 
sis on polyacrylamide gel demonstrated that ascitic 
and  blood  plasma  of  the  tumor-bearing  animals 
have the  same  protein  composition  (Paoletti  and 
Olivotto,  manuscript  in  preparation).  Rapid  and 
extensive  exchanges  between  blood  and  ascitic 
plasma  have  also  been  demonstrated  for  low 
molecular weight substances such  as glucose (8). 
It  should  be  mentioned  that,  when  proteins  of 
ascites tumor cells are to be labeled with radioac- 
tive amino acid, lysine in our case, the concentra- 
tion of this amino acid in the ascitic plasma and in 
the blood must be evaluated. 
Whatever the tumor size, lysine concentration in 
the ascitic plasma is constant (0.530 umol/ml) and 
in equilibrium  with the concentration in the blood 
(0.508 pmol/ml). 
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(see  Materials  and  Methods)  it  is  possible  to 
evaluate the total lysine pool in this fluid for each 
tumor. 
At this point a tentative estimation of the initial 
specific activity of the labeled lysine injected, after 
the  dilution  in  the  ascitic pool,  was  carried  out 
without  taking  into  account  for  the  moment  the 
extraascitic compartment. 
The formula applied was: 
Ao  #Ci  (i) 
K  +(C.V) 
where Ao  =  initial specific activity of the lysine in 
the  ascitic compartment;  ~Ci  =  radioactivity of 
the lysine injected (a constant); K  =  micromoles of 
lysine  injected  (a  constant);  C  =  micromoles of 
lysine per milliliter of ascitic plasma (a constant); 
V  =  ascitic plasma volume (milliliters). 
If the lysine transport capacity remains constant 
throughout  the  tumor  phases,  it  is reasonable to 
assume that the specific activity of proteins made 
up  at  the  same  rate  of synthesis  by  tumors  of 
different sizes is proportional to the specific activ- 
ity  of  the  labeling  amino  acid  in  the  ascitic 
compartment. 
Experiments in vitro measuring the lysine trans- 
port capacity in log and in  resting cells (Table  I) 
showed  no  substantial differences in  tumor cells 
harvested, respectively, at the 4th and the 10th day 
after transplantation. 
Experiments  carried  out  in  vivo  indicate  that 
also under this condition the amino acid transport 
capacity is unchanged in log vs. resting phase cells. 
Letting As and A~ represent the specific activity 
TABLE  I 
L-Lysine Transport Capacity in Log and Resting 
Phase Cells of Yoshida Ascites Hepatoma 
Days after  Intracel- 
transplan-  Tumor  lular  Dislribution 
tation  volume  water*  ratiot 
ml 
4  30  3.89  3.68 
10  90  3.22  3.28 
Samples  were incubated  5 min at 37°C  in Krebs-Hen- 
seleit bicarbonate buffer containing L-[a4Cllysine. 
For details seee Materials and Methods. 
* Microliter per milligram of cellular protein. 
t dpm/milliliter of intracellular water/dpm/milliliter of 
extracellular water. 
of free lysine in the ascitic plasmas of animals l and 
i,  as  calculated  according  to  Eq.  i,  and  P~,  P~ 
represent the corresponding tumor protein specific 
activity, then, having measured Pz, it is possible to 
compare  the  experimental  value  of  P~  with  its  A 
expected P~ derived according to Eq. 2a: 
/b = e~ A....L,  (2a) 
Al 
One may also derive from the measured value of 
P~ another value P~c, which takes into account the 
dilution effect: 
P~c = P, Az  (2b) 
Ai 
After determining the experimental value of P~ 
in  a  tumor  of  12  ml,  Eq.  2a  permitted  the 
calculation of the decline of specific activity to be 
expected solely on the basis of the label dilution in 
the increasing ascitic plasma volumes, in proteins 
synthesized at  the  same  rate  by different tumors 
(Fig.  1, dotted line). 
In Fig. 2 the experimental counts per minute per 
milligram of cellular protein labeled with  [3H]ly- 
sine are also plotted against tumor total volume. 
Experimental points (open circles) fall close to the 
calculated  line  while  cell  proteins  increase  at  a 
constant  rate.  As  the  cellular  mass  reaches  its 
steady-state, experimental values depart from this 
line although they are fitted by a curve of the same 
shape.  A  correction  according  to  Eq.  2b  of the 
experimental counts  per minute  per milligram of 
protein  (full  circles)  makes  it  more  clear  that 
during the log phase the decline of specific activity 
of the cell proteins can only be accounted for by 
the increase of the lysine pool in the ascitic plasma. 
The same explanation applies to the decline of the 
protein specific activity measured during the rest- 
ing  phase,  while  in  this  stage  the  values  are 
constantly 30%  lower than in the log phase. 
The  following conclusions can  be  drawn  from 
the results so far presented. When the cell mass has 
a uniform growth rate, protein synthesis proceeds 
at a constant rate. This may be deduced from the 
fact that at this stage radioactivity from [aH]lysine 
incorporation into proteins corresponds closely to 
that  calculated  according  to  the  dilution  effect, 
assuming  constant  rates  of  lysine  uptake  and 
protein  synthesis.  This  correspondence  indicates 
that  the  amount  of labeled amino  acid  escaping 
from  the  ascitic  compartment  is  negligible  in 
comparison with the amount  remaining. 
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FIGURE  2  Incorporation  of [SH]lysine into cell proteins at various stages of tumor growth.  All values 
refer to 80 min after the injection of [~H]lysine and are reported as experimentally determined (O  ©), 
as predicted according to Eq. 2a ( ..... ) or corrected taking into account the dilution effect according to 
Eq.  2b  (O  I).  Total  cell  mass  is  expressed  as  milligrams  of tumor  cell protein  (11---II).  For 
explanation see Results and  Discussion. 
As the cellular mass reaches the steady-state, the 
rate  of protein  synthesis  settles at  a  value that  is 
30%  lower  than  in  the  log  phase,  but  remains 
constant  throughout  the resting phase. 
The last conclusion is also supported  by the fact 
that the amount of lysine taken up by the cells and 
newly  supplied  from  the  blood  was  found  to  be 
constant  during  the  resting  phase.  This  finding 
derives  from  the  measurements  of  the  specific 
activity  (At)  of  free  lysine  in  the  ascitic  plasma 
withdrawn  immediately  after  animal  killing,  i.e., 
80 min after the injection of the labeled amino acid 
(see  Table  II).  From  Eq.  i  the  initial  specific 
activity  (At)  of  free  lysine  in  the  ascitic  plasma 
of labeled amino acid (Ao) can also be calculated. 
It  is thus  possible  to  estimate  the amount  of the 
initial  pool  which  should  have  remained  as  free 
lysine  in  the  ascitic compartment  after  the  inter- 
val 0  -  t: 
At 
O = Lo--  (3) 
Ao 
where  Q  =  amount  of  the  initial  pool  (Lo) 
remaining  in  the  ascitic  compartment  at  time  t 
(micromoles); Lo =  lysine pool (micromoles) in the 
ascitic  plasma  at  time  zero  [initial  pool;  K  + 
(C. 1  I) of Eq.  1]; Ao  =  specific activity (microcu- 
ries/micromole) of [SH]lysine at time zero (calcu- 
lated from Eq.  1); At  =  specific activity (microcu- 
ries/micromole) of [3H]lysine at time t. 
Let us  consider, e.g., the 57-ml tumor  of Table 
II. Ao can be estimated as 1.46 pCi/pmol, whereas 
At  =  0.264  uCi/pmol,  that  is,  5.5  times  lower. 
This  implies  that  1/5.5  (At/Ao)  of  Lo  is  the 
amount  of the initial pool remaining in the ascitic 
compartment  at time t. 
The  amount  of lysine taken  up by the cells and 
replaced by unlabeled amino acid coming from the 
blood (R) can then be calculated: 
R  = Lo  -  Q  (4) 
For all the tumors  considered  in Table  II, R  is 
constant  (28.8  ±  1 pmol). The value of Q, on the 
contrary,  increases  concurrently  with  the  ascitic 
plasma  volume  or,  in  other  words,  with Lo.  This 
makes understandable the fact that the experimen- 
tal values of At rise, although Ao decreases, when 
the  tumor  volume  increases.  In  fact,  the  same 
amount  (R)  is  renewed  in  the  interval  0  -  t  in 
tumors  having  different  total  lysine  pools.  Thus, 
the smaller Lo  and  then  the higher Ao values, the 
smaller the amount of Lo remaining in the ascitic 
compartment  (Q)  and  undergoing  the dilution  by 
the amino acid renewed from the blood. 
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[3H]L ysine Specific Activities in the Ascitic Plasmas of Yoshida Ascites Hepatomas Immediately and 80 min 
after the Injection of Isotope into Tumors having Similar Cell Masses and Different Ascites  Volumes 
Ascitic 
Tumor  plasma 
volume  volume  Cell mass  Ao  Lo  Q  R  A t 
ml  ml  mg protein  t~Ci/t~mol  ~zmol  •mol  ttmol  #Ci/tzmol 
57  53.2  1,155  1.46  34.2  6.2  28.0  0.264 
67  63.3  1,165  1.26  39.6  9.3  30.3  0.298 
71  67.5  I, 100  1.19  41.7  I 1.0  30.7  0.313 
94  91.1  900  0.92  54.3  28.0  26.3  0.475 
For explanation see Results and Discussion. 
Ao  =  specific  activity of[3H]lysine at time zero (calculated from Eq. 1). 
Lo  =  lysine pool at time zero in the ascitic plasma [K -  (C. V)] of Eq.  1. 
Q  =  amount of Lo remaining in the ascitic plasma at time t (calculated from Eq. 3). 
R  =  amount oflysine taken up by the cells and replaced from the blood in the interval 0 -  t (calculated from Eq. 4). 
At  =  specific activity of [aH]lysine  experimentally  determined at time t (80 min after the isotope injection). 
After determining R for one tumor, substituting, 
in Eq. 4, Lo (At/Ao)  for Q and calculating Lo and 
Ao  for each  tumor,  At  can be predicted  for  any 
tumor having the same cellular mass: 
At = Ao,  Lo -  R  (5) 
Lo 
From the above reported data, it is also possible 
to estimate the rate of utilization of lysine per hour 
and per microgram of cell protein as 18 pmol, that 
is, a value of the same order as the  10.8 found by 
Kruse  et  al.  for  perfused  Jensen  sarcoma  cells 
throughout different phases of proliferation (14). 
Concurrently with the rate of synthesis studied 
by  short-time  [3H]lysine  incorporation,  protein 
degradation was followed by measuring the decline 
of  [14C]protein  radioactivity  after  labeling with 
[14C]lysine (see Materials and Methods). 
Fig. 3 shows  [l'C]protein radioactivity of hepa- 
tomas at various times after [x4C]lysine injection. 
Fig. 3 A and B refer to tumors, labeled while in the 
growing phase and Fig. 3 C and D refer to tumors 
labeled while already in the resting phase. Results 
are reported both as radioactivity per milligram of 
cell protein (Fig. 3 A and C) and as radioactivity of 
the total tumor cells (Fig. 3B and D).  The latter 
reference  is  necessary when dealing with  a  mass 
that  is changing during the time of the measure- 
ment. 
14C  radioactivity per  milligram of cell protein 
rapidly drops as the tumor mass increases, and it 
continues to fall, although at a  slower rate, when 
the cell mass settles at the steady-state (Fig. 3 A). 
On  the  contrary,  the  total  radioactivity  keeps 
increasing throughout  the  log  phase  (Fig.  3  B) 
although the specific activity of free iysine in the 
ascitic plasma drops dramatically a few hours after 
the isotope injection (Fig. 3 B and D, dotted lines). 
The continuing increase of the total radioactivity 
of cell proteins~  even when the specific activity of 
the labeling amino acid in the biological fluids is 
very low,  has already been reported by LePage et 
al. as a peculiarity of cancer (15). 
The total radioactivity increases at this stage 2.5 
times, whereas the cell proteins increase 4.4 times. 
The decrease of counts per minute per milligram of 
cell protein seems, therefore, to be accounted for 
mostly by the increase in tumor mass. Neverthe- 
less, it is impossible to exclude protein degradation 
during this  stage,  since any loss  of radioactivity 
would be masked by the continuing  incorporation. 
During the resting phase the total radioactivity 
declines along with the specific one. This happens, 
starting from zero time, in experiments where the 
isotope  injection is  carried  out  when  the  tumor 
mass has already attained the steady-state (Fig. 3 
C  and D).  In these experiments there is no initial 
increase  of  the  total  radioactivity,  which  seems 
therefore  essentially related  to  the  log  stage  of 
growth of these cells. 
On the whole, these conclusions are suggested by 
the results reported in Fig. 3. During the log phase, 
protein catabolism, if present, is by far exceeded 
by  the  synthetic  process,  whereas,  during  the 
resting  phase,  protein  degradation  is  counter- 
balancing  the  synthesis  that  is  still  very  high 
throughout this period (see discussion of Fig. 2). 
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state,  it was possible to gather some information 
about the protein turnover of subcellular particles. 
During the resting phase, the total protein half-life 
for  microsomes (estimated from  semilogarithmic 
plots  of  counts  per  minute  per  milligram  of 
protein) was approximately 3 days. This value is 
close to that reported by other authors for rat liver 
microsomes (2,  20).  For tumor mitochondria, the 
total protein half-life was estimated ~o be around 5 
days, in agreement with the findings reported for 
liver mitochondria (25).  In the nuclear fraction the 
half-life estimated to be around 3 days is apprecia- 
bly shorter than that reported by Arias et al. (2) fo~ 
nuclear proteins of rat liver. 
Since sufficient information about the effect of 
precursor  reutilization  is  lacking,  the  half-lives 
reported have to be considered as possibly overesti- 
mated (10). 
It should be said that the release of proteins by 
the cells into the surroundings (14,  28)  may alter 
the measurement of turnover based on the decay of 
the specific activity of cell proteins, as the radioac- 
tivity loss may  be  wrongly attributed to  catabo- 
lism. 
Fig.  4  shows  that  at  the  time  of  the  tumor 
harvesting, i.e., 80 min after the isotope injection, 
blood plasma proteins are highly labeled, whereas, 
in the ascitic plasma, labeled proteins appear only 
later, reaching a plateau which lasts about 3 days. 
The  rise  of  the  protein  specific  activity  in  the 
ascitic compartment is simultaneous with the drop 
of the specific  activity in the blood, until the same 
value is  attained in the two compartments. Even 
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FIGURE 3  Time-course of tumor cell protein radioactivity (O  O) after labeling with [  14C]lysine.  At the 
time of the injection of [14C]lysine,  the tumors were 5-days old with the cell mass (A  A) still actively 
increasing (Fig. 3 A and B), or 7-days old with the cell mass at the steady-state (Fig. 3 C and D). The dotted 
lines represent the specific activity of free [14C]lysine  in the ascitic plasma. 
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FIGURE 4  Time-course of protein labeling in the ascitic 
and blood plasmas.  Rats at 7 days after transplantation 
were given i.p. 10 pCi of []'C]lysine and killed at various 
times thereafter. (e  e)  =  specific activity of blood 
plasma proteins; (©  O)  =  specific activity of ascitic 
plasma  proteins;  (A  A)  =  total  radioactivity  of 
ascitic plasma proteins. 
then, the total radioactivity of the ascitic proteins 
continues to increase. 
These  findings suggest that radioactive proteins 
in the ascitic plasma mainly derive from the blood 
plasma,  which  continuously  passes  into  and  is 
retained  in  the  ascitic  compartment,  accounting 
for  the  kinetics  of  appearance  of  the  labeled 
proteins  therein.  Release  of  cellular  mac- 
romolecules affecting these kinetics does not seem 
to take place. This is in keeping with the view that 
the decline of the specific activity of cell proteins 
reported in Fig. 3 is due to intracellular catabolism 
rather  than  to  macromolecular  release.  Some 
experiments  carried  out  in  vitro  indicate  that 
macromolecules  released  by  the  tumor  cells  are 
less than  5%  of the total TCA-precipitable mate- 
rial. 
Concluding Remarks 
The  results  so  far  presented  and  discussed 
encourage the use of the Yoshida ascites hepatoma 
as a  useful model for studying protein metabolism 
in relation to cell growth in vivo. 
The  time-course  of  the  tumor  development 
offers the  possibility of following a  homogeneous 
cell population that, while remaining metabolically 
very active, undergoes a great modification of the 
proliferation rate. The modification of the equilib- 
rium  between  protein  synthesis  and  degradation 
and not a metabolic depression is strictly related to 
the  arrest  of the  cellular  mass  increase  attained 
during the resting phase. 
A profitable feature of this tumor lies in the fact 
that  most  of the  labeled amino acid  injected i.p. 
into the  animals is immediately available for the 
cells  within,  with  only a  minor loss  towards  the 
extraascitic  compartment.  Furthermore,  the 
amino acid transport capacity of the cells does not 
change in log vs. resting phase.  It is thus possible 
to evaluate the time-course of the protein synthesis 
after  taking  into  account  the  dilution  of  the 
labeling amino acid in the ascitic pool. 
To further stress the interest in this model,  the 
arrest  of cell proliferation  cannot be  ascribed  to 
contact or density inhibition, as the cell crowding 
in the ascitic plasma decreases during the resting 
period. 
It is also difficult to conceive an immunological 
mechanism  which  arrests  tumor  growth  without 
leading to tumor regression. 
Energy supply does not appear to be the growth- 
limiting factor, as it is at least sufficient to sustain 
amino acid transport  as well as protein synthesis 
and degradation at similar rates in the two stages. 
However, within 6-7 days after tumor transplanta- 
tion,  glucose  concentration of the  ascitic plasma 
shows a  20-time decrease (7). The decrease of the 
glucose level may be related to the arrest of the cell 
growth,  although  the  precise  underlying mecha- 
nism  remains  rather  speculative.  In this connec- 
tion, one recalls that  in Escherichia coli the cyclic 
AMP level was found to be depressed  by glucose 
(21), and that in mammalian cells the cyclic AMP 
concentration  is  inversely  related  to  the  rate  of 
DNA synthesis (1). 
Glucose  availability  may  also  be  relevant  in 
regard to the pattern and/or the metabolic rate of 
the  carbohydrate-containing  macromolecules.  In 
fact, glucose is the source of the carbohydrates of 
the  cell surface, whose structure and functions are 
important in cell cycle regulation (24, 27, 9, 5, 26). 
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